Hayes, Oliver G., Vangaveti, Venkat N., and Malabu, Usman H. (2016) Diagnostic performance of serum bone turnover marker lysylpyridinoline in diabetic foot osteomyelitis: a preliminary study. Clinical Medicine and Diagnostics, 6 (3). pp. 49-53.

Preview

PDF (Published Version) - Published Version Available under License Creative Commons Attribution. Download (208kB) | Preview

Abstract

Objectives: The aim of the study was to determine whether serum levels of lysylpyridinoline (LP) differ between diabetic foot osteomyelitis (DFO) and diabetic foot ulcers without osteomyelitis (cellulitis).

Methods: A case controlled study was designed comparing the aforementioned groups. Subjects were classified as osteomyelitis and controls based on the International Working Group diagnostic criteria. Serum LP samples were analysed using enzyme linked immunosorbent assay.

Results: The serum LP levels were significantly higher in the DFO group (n: 16) than the control group (n: 11): LP median ± SD of 9.3 ± 3.5 nmol/l, interquartile range (IQR) 6.8-11.2 in DFO compared to 2.1 nmol/l 3.5, IQR 0.7-4.2 in the controls, p=0.001. The receiver operator characteristic curve in the DFO was 0.9. The diagnostic sensitivity, specificity, positive and negative predictive values were 100%, 77.8%, 89.0% and 100% respectively.

Conclusions: This appears to be the first evidence of serum LP elevation in diabetic foot osteomyelitis with potential diagnostic value in clinical setting.

Item ID:	44495
Item Type:	Article (Scholarly Work)
ISSN:	2163-1441
Keywords:	bone turnover markers, diagnosis, diabetic foot osteomyelitis
Related URLs:	Publisher
Additional Information:	Copyright © 2016 Scientific & Academic Publishing. All Rights Reserved
Date Deposited:	20 Jul 2016 03:21
FoR Codes:	11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110306 Endocrinology @ 100%
SEO Codes:	92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920104 Diabetes @ 100%
Downloads:	Total: 191 Last 12 Months: 8
	More Statistics